## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T
โฆ LIBER โฆ
Role of novel targeted therapies in the clinic
โ Scribed by Herbst, R S
- Book ID
- 109998525
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 113 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Novel targeted therapies in inflammatory
โ
Massimo Cristofanilli
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 84 KB
๐ 2 views
The role of new targeted therapies in sm
โ
A Rossi; P Maione; G Colantuoni; C Guerriero; C. Gridelli
๐
Article
๐
2004
๐
Elsevier Science
๐
English
โ 101 KB
Development of novel targeted therapies
โ
Rich, Jeremy N.; Bigner, Darell D.
๐
Article
๐
2004
๐
Nature Publishing Group
๐
English
โ 576 KB
Revisiting the role of molecular targete
โ
Dionysis Papadatos-Pastos; Udai Banerji
๐
Article
๐
2011
๐
Springer US
๐
English
โ 191 KB
Transcending conventional therapies: The
โ
Dr. William J. Sandborn
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 883 KB
Biologic and other novel therapies targeted to specific pathogenic processes offer the potential for improved treatment outcomes in patients with Crohn's disease and alteration of the course of the disease. Therapies targeted to tumor necrosis factor alpha (TNF-alpha) include anti-TNF-alpha monoclon
Clinical experience of targeted therapy
โ
Hans-Georg Eichler
๐
Article
๐
1991
๐
Springer
๐
English
โ 994 KB